As a leading R&D institution and product supplier of Nitrogen eterocyclic (acridine) series and Boron cluster (carborane) series products, Zhengzhou Yuanli Technology fully demonstrated its comprehensive scientific research strength and industrialization ability at this exhibition. During the exhibition, the team received overseas customers from multiple countries and heads of domestic pharmaceutical companies, focusing on promoting the company's core products such as pharmaceutical intermediates, nitrogen heterocycles, and boron clusters.<br>
Zhengzhou Yuanli Technology has been deeply involved in the field of pharmaceutical and fine chemicals for many years, adhering to the development concept of "being one of the best companies in transforming new technologies into applications", and has built a fully integrated system from research and development, pilot testing to mass production. Its products are exported to more than 70 countries and regions, and are trusted by customers with stable quality and professional services.<br>
This exhibition has come to a successful conclusion. Next, Mr. Wu will lead his team to seize the opportunity of cooperation at the exhibition, accelerate the conversion of intended orders, continue to increase technological innovation, actively expand the pharmaceutical market at home and abroad, and work together with partners to win new opportunities in the industry.
